Omnes Capital Founded 1999
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 179
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 161
Rounds per year 7.32
Lead investments 34
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.16
Exits 59
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity
Seed
Areas of investment
Biotechnology
Health Care
Industrial
Software
Telecommunications
Summary

Omnes Capital is the famous VC, which was founded in 1999. The venture was found in Europe in France. The leading representative office of defined VC is situated in the Paris.

Besides them, we counted 19 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Omnes Capital, startups are often financed by Bpifrance, Ventech, Societe Generale Asset Management. The meaningful sponsors for the fund in investment in the same round are Bpifrance, Andera Partners, Seventure Partners. In the next rounds fund is usually obtained by Andera Partners, Ventech, Seventure Partners.

The top activity for fund was in 2009. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Omnes Capital performs on 12 percentage points more the average number of lead investments. Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2015. The fund is constantly included in 7-12 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.

We can highlight the next thriving fund investment areas, such as Medical Device, Internet. Among the most popular portfolio startups of the fund, we may highlight PayPal, Scality, BioVex. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - France. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
AgomAb Therapeutics
Biotechnology
Health Care
Therapeutics
Early Stage Venture
74M10 Mar 2021 Belgium, Ghent
BIZAY / 360imprimir
B2B
Made to Order
Late Stage Venture
38M03 Dec 2020 Portugal, Santa Maria, São Pedro e Matacães
Biosyl
Energy
21 Oct 2020 France, " France"}
SEKOIA
Cyber Security
Software
Early Stage Venture
11M07 Oct 2020 France, Paris
AB Tasty
A/B Testing
Analytics
Artificial Intelligence
Usability Testing
Late Stage Venture
40M22 Jul 2020 France, Paris
ENTEROME
Biopharma
Biotechnology
Drug Discovery
Health Care
Life Science
Late Stage Venture
46M25 Jun 2020 France, Paris
TISSIUM
Biotechnology
Health Care
Medical Device
Early Stage Venture
45M20 Nov 2019 France, Paris
4M29 Oct 2019
Energy
Venture - Series Unknown
08 Oct 2019 France, " France"}
News
Coave Therapeutics Closes €33M in Series B Financing
– Coave Therapeutics, a Paris, France-based clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases, raised a €21.2m ($25.1m) expansion of its Series B funding round, bringing the total raised to €33.1m ($39m). – This round was led by Seroba Life Sciences, supported by new investors Théa Open Innovation and eureKARE alongside existing shareholders Fund+, Omnes Capital, V-Bio Ventures, Kurma Partners, Idinvest, GO Capital, and Sham... Read more
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Omnes Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: